참고문헌
- C. Spencer and D. Faulds, Paclitxel; A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer, Drugs 48, 794-847 (1994) https://doi.org/10.2165/00003495-199448050-00009
- B. Tarr., T. Sambandan and S. Yalkowsky, A new parenteral emulsion for the administration of Taxol, Pharm. Res., 4, 162-165 (1987) https://doi.org/10.1023/A:1016483406511
- P. Crosasso, M. Ceruti, P. Brusa, S. Arpicco, F. Dosio and L. Cattel, Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes, J. Controlled Rel., 63, 19-30 (2000) https://doi.org/10.1016/S0168-3659(99)00166-2
- H. Alkan-Onyuksel, S. Ramakrishnan, H. Chai and J. Pezzuto, A mixed micellar formulation suitable for the parenteral administration of Taxol, Pharm. Res., 11, 206-212 (1994) https://doi.org/10.1023/A:1018943021705
- U Sharma, S. Balasubramanian and R. Straubinger, Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins, J. Pharm. Sci., 84, 1223-1230 (1995) https://doi.org/10.1002/jps.2600841015
- L. Mu and S. Feng, Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-eo-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers, J. Controlled Rel., 76, 239-254 (2001) https://doi.org/10.1016/S0168-3659(01)00440-0
- R. Cavalli, O. Caputo and M. Gasco, Preparation and characterization of solid lipid nanospheres containing paclitaxel, Eur. J. Pharm. sa: 10, 305-309 (2000) https://doi.org/10.1016/S0928-0987(00)00081-6
- R. Muller, W. Mehnert, J. Lucks, C. Schwarz, A. Muhlen, H. Weyhers, C. Freitas and D. Ruhl, Solid lipid nanoparticles (SLN)-An alternative colloidal carrier system for controlled drug delivery, Eur: J. Pharm. Biopharm., 41, 6269 (1995)
- W. Mehnert and K. Mader, Solid lipid nanoparticles: production, characterization and applications, Adv. Drug Del. Rev., 47, 165-196 (2001) https://doi.org/10.1016/S0169-409X(01)00105-3
- R. Muller and W. Mehnert, Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes, J. Controlled ReI., 47, 261-269 (1997) https://doi.org/10.1016/S0168-3659(97)01653-2
- D. Chen, T. Yang, W. Lu and Q. Zhang, In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel, Chem. Pharm. Bull., 49, 1444-1447 (2001) https://doi.org/10.1248/cpb.49.1444
- S. Lee, S. Yoo and K. Lee, Rapid and sensitive determination of paclitaxel in mouse plasma by HPLC, J. Chromatogr. B., 724, 357-363 (1999) https://doi.org/10.1016/S0378-4347(98)00566-0
- G. Basileo, M. Breda, G. Fonte, R. Pisano and C. James, Quantitative determination of paclitaxel in human plasma using semi-automated liquidliquid extraction in conjunction with liquid chromatography/tandem mass spectrometry, J. Pharm. Biomed. Anal., 32, 591-600 (2003) https://doi.org/10.1016/S0731-7085(03)00166-3
- L. He, G. Wang, and Q. Zhang, An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile, Int.J. Pharm., 250, 45-50 (2003) https://doi.org/10.1016/S0378-5173(02)00478-7
- S. Kim, D. Kim, Y. Shim, J. Bang, H. Oh, S. Kim and M. Seo, In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy, J. Controlled Rel., 72, 191-202 (2001) https://doi.org/10.1016/S0168-3659(01)00275-9